ZA874626B - Azabicyclic compounds,process and intermediates for their preparation and pharmaceutical compositions containing them - Google Patents

Azabicyclic compounds,process and intermediates for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA874626B
ZA874626B ZA874626A ZA874626A ZA874626B ZA 874626 B ZA874626 B ZA 874626B ZA 874626 A ZA874626 A ZA 874626A ZA 874626 A ZA874626 A ZA 874626A ZA 874626 B ZA874626 B ZA 874626B
Authority
ZA
South Africa
Prior art keywords
intermediates
preparation
pharmaceutical compositions
compositions containing
azabicyclic compounds
Prior art date
Application number
ZA874626A
Other languages
English (en)
Inventor
Michael Stewart Hadley
Stewart Hadley Michael
Harry John Wadsworth
John Wadsworth Harry
Barry Sidney Orlek
Sidney Orlek Barry
Howard Elliott Rosenberg
Elliott Rosenberg Howard
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA874626B publication Critical patent/ZA874626B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA874626A 1986-06-27 1987-06-26 Azabicyclic compounds,process and intermediates for their preparation and pharmaceutical compositions containing them ZA874626B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615785A GB8615785D0 (en) 1986-06-27 1986-06-27 Compounds

Publications (1)

Publication Number Publication Date
ZA874626B true ZA874626B (en) 1988-08-31

Family

ID=10600224

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874626A ZA874626B (en) 1986-06-27 1987-06-26 Azabicyclic compounds,process and intermediates for their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
US (1) US4870081A (de)
EP (1) EP0257741A3 (de)
JP (1) JPS6339879A (de)
AU (1) AU599990B2 (de)
DK (1) DK324387A (de)
GB (1) GB8615785D0 (de)
NZ (1) NZ220840A (de)
PT (1) PT85173B (de)
ZA (1) ZA874626B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287356B1 (de) * 1987-04-15 1996-01-24 Beecham Group Plc Am Brückenkopf substituierte Azabicyclenderivate
DK177889A (da) * 1988-04-15 1989-10-16 Beecham Group Plc Hidtil ukendte forbindelser
EP0363085A3 (de) 1988-10-03 1991-03-27 Beecham Group Plc Chemische Verbindungen
CA2000041A1 (en) * 1988-10-13 1990-04-13 Barry S. Orlek Compounds
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
GB8911080D0 (en) * 1989-05-15 1989-06-28 Merck Sharp & Dohme Chemical process
YU84791A (sh) * 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
IE912974A1 (en) * 1990-08-24 1992-02-26 Beecham Group Plc Novel compounds
GB9019095D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
JPH06501933A (ja) * 1990-10-12 1994-03-03 ビーチャム・グループ・パブリック・リミテッド・カンパニー 1,2,5,6−テトラヒドロピリジン・オキシム誘導体
HU209451B (en) * 1990-11-05 1994-06-28 Gyogyszerkutato Intezet Process for the production of 1-azabicyclo-alkan -derivatives and pharmaceutical preparations containing the same
US5244906A (en) * 1992-01-23 1993-09-14 Dowelanco Insect control with substituted oxadiazole and thiadiazole compounds
US5468875A (en) * 1994-12-22 1995-11-21 American Home Products Corporation 1-azabicycloheptane derivatives
US5668144A (en) * 1995-11-08 1997-09-16 American Home Products Corporation 1-azabicyclopheptane derivatives
US5773458A (en) * 1996-10-30 1998-06-30 American Home Products Corporation 1-azabicycloheptane derivatives
US6875774B2 (en) 2002-08-06 2005-04-05 The University Of North Carolina Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP1928437A2 (de) * 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese mittels muscarinrezeptormodulation
EP2068872A1 (de) 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
WO2012033956A1 (en) * 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658067A (en) * 1953-11-03 Substituted carbamic acdj esters
DE1470084A1 (de) * 1964-08-19 1969-05-29 Merck Ag E Verfahren zur Herstellung von substituierten Piperidin-derivaten
US3501471A (en) * 1966-09-21 1970-03-17 American Cyanamid Co Novel 2,3-heterocyclic fused quinuclidines,and 3-substituted quinuclidine-2-carboxylate derivatives
US3681363A (en) * 1970-08-20 1972-08-01 Univ Temple Spiro(imidazolidine-4,3{40 -quinuclidine)-2,5-diones
US4038402A (en) * 1974-03-05 1977-07-26 Mikhail Emmanuilovich Kaminka Method of effecting antihistaminic, antiserotonin and antiallergic actions
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
NZ203861A (en) * 1982-04-14 1986-07-11 Beecham Group Plc Bicyclic heterocyclic compounds and pharmaceutical compositions containing such
FR2526433B1 (fr) * 1982-05-04 1985-10-18 Pharmuka Lab Isomeres dextrogyres de derives de l'aza-1 bicyclo (2,2,2) octane, leur procede de preparation et medicaments les contenant
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
SE461171C (sv) * 1988-05-25 1992-08-17 Valmet Paper Machinery Inc Press med laangt nyp foer pappers- eller kartongmaskiner

Also Published As

Publication number Publication date
GB8615785D0 (en) 1986-08-06
DK324387D0 (da) 1987-06-25
EP0257741A3 (de) 1989-09-06
US4870081A (en) 1989-09-26
AU7469487A (en) 1988-01-07
PT85173A (en) 1987-07-01
PT85173B (pt) 1990-03-30
JPS6339879A (ja) 1988-02-20
EP0257741A2 (de) 1988-03-02
AU599990B2 (en) 1990-08-02
DK324387A (da) 1987-12-28
NZ220840A (en) 1990-08-28

Similar Documents

Publication Publication Date Title
DE3666036D1 (en) Phenylethanol aminotetralines, process for their preparation and pharmaceutical compositions containing them
HUT42321A (en) Process for preparing pharmaceutical compositions
EP0255297A3 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
EP0094742A3 (en) Substituted azabicyclo compounds, process for their preparation, pharmaceutical compositions containing them, and their use
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
LTIP1467A (en) Tertiary hydroxyalkylxantines, process for the preparation thereof and pharmaceutical composition containing them
ZA874626B (en) Azabicyclic compounds,process and intermediates for their preparation and pharmaceutical compositions containing them
IL85741A0 (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and pharmaceutical compositions containing them
EP0254584A3 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
EP0289170A3 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
HUT49481A (en) Improved process for producing pharmaceutical compositions containing calcium-salts
EG17710A (en) Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them
GR3001416T3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
EP0290915A3 (en) Flavone-3-carboxylic-acid compounds, and process, intermediates for their preparation and medicines containing these compounds
EP0172004A3 (en) Quinolinones, process for their preparation and pharmaceutical compositions containing them
ZA876540B (en) New sulphonamidoethyl compounds,pharmaceutical compositions containing these compounds and processes for preparing them
ZA873638B (en) New immunosuppressant substances,process for their preparation and pharmaceutical compositions containing them
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
IL84955A0 (en) Novel carbamoyloxylabdanes,process for the preparation thereof and pharmaceutical compositions containing them
DE3664635D1 (en) 7-hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
IL82333A (en) Substituted 2-phenylbenzothiazin-3-one derivatives,process for their preparation and pharmaceutical compositions containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
IL81978A (en) Indenopyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
PT86455A (en) Process for the preparation of pharmaceutical compositions containing pyranoquinoline derivatives